|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Research and development expenses, net | |||||
| Marketing, general and administrative expenses | |||||
| Other income | |||||
| Total operating expenses | |||||
| Total financial income, net | |||||
| Total operating loss | |||||
| Gain on troubled debt restructuring | |||||
| Financial income (expenses) net, | |||||
| Net Income (Loss) | |||||
| Net loss (Income) per ordinary share attributable to shareholders, basic (in Dollars per share) | |||||
| Net loss (Income) per ordinary share attributable to shareholders, diluted (in Dollars per share) | |||||
| Weighted average number of shares used in computing net loss (income) per share attributable to ordinary shareholders, basic (in Shares) | |||||
Loading...